This is a preview of subscription content, log in via an institution to check access.
Reference
Ronald LA, et al. Treatment with Isoniazid or Rifampin for Latent Tuberculosis Infection: Population-Based Study of Hepatotoxicity, Completion, and Costs. European Respiratory Journal : 24 Jan 2020. Available from: URL: http://doi.org/10.1183/13993003.02048-2019
Rights and permissions
About this article
Cite this article
Rifampicin reduces severe hepatotoxicity and costs versus isoniazid. PharmacoEcon Outcomes News 846, 25 (2020). https://doi.org/10.1007/s40274-020-6564-4
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-020-6564-4